Dextenza

Eyes itching from allergies? Ocular's Dextenza wins FDA approval as first monthly implant
Fierce Pharma
Tue, 10/12/21 - 11:47 am
Ocular Therapeutix
Dextenza
allergic conjunctivitis
FDA
Ocular Therapeutix announces topline results of phase 3 trial of dextenza for treatment of ocular itching associated with allergic conjunctivitis
Pharmaceutical Business Review
Wed, 04/29/20 - 10:48 pm
Ocular Therapeutix
clinical trials
Dextenza
allergic conjunctivitis
Ocular Therapeutix resubmits NDA for ocular pain relief implant
Drug Delivery Business News
Fri, 06/29/18 - 09:23 pm
Ocular Therapeutix
ocular pain relief
FDA
Dextenza
devices
SEC subpoenas Ocular Therapeutix over pain relief implant
Drug Delivery Business News
Wed, 12/27/17 - 09:43 am
SEC
Ocular Therapeutix
pain relief implant
Dextenza
post-surgical pain
Ocular Therapeutix Hit by Subpoena, SEC Seeks Eye Pain Drug Documents
Xconomy
Sat, 12/23/17 - 11:55 am
Ocular Therapeutix
SEC
eye pain
Dextenza
Ocular Therapeutix slashes workforce following FDA rejection
Drug Delivery Business News
Wed, 08/2/17 - 09:20 am
Ocular Therapeutix
layoffs
FDA
devices
Dextenza
FDA rejects Ocular Therapeutix eye drug, citing manufacturing issues
Stat
Wed, 07/12/17 - 12:06 am
FDA
Ocular Therapeutix
Dextenza
Ocular touts patient experience data for Dextenza implant
Drug Delivery Business News
Wed, 03/15/17 - 10:15 am
devices
Ocular Therapeutix
eye health
Dextenza
post-surgical pain
Ocular Therapeutix touts data from phase III trial of Dextenza
Mass Device
Wed, 01/4/17 - 10:51 am
Ocular Therapeutix
Dextenza
devices
post-surgical ocular inflammation and pain
eye health
FDA rejects Ocular Therapeutix’ Dextenza post-operative pain indication
Mass Device
Tue, 07/26/16 - 11:05 am
FDA
devices
Ocular Therapeutics
Dextenza
post-operative pain